Cargando…
Effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial
BACKGROUND: Acidosis-induced kidney injury is mediated by the intrarenal renin-angiotensin system, for which urinary renin is a potential marker. Therefore, we hypothesized that sodium bicarbonate supplementation reduces urinary renin excretion in patients with chronic kidney disease (CKD) and metab...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494695/ https://www.ncbi.nlm.nih.gov/pubmed/33382448 http://dx.doi.org/10.1007/s40620-020-00944-5 |
_version_ | 1784579369812885504 |
---|---|
author | Bovée, Dominique M. Roksnoer, Lodi C. W. van Kooten, Cornelis Rotmans, Joris I. Vogt, Liffert de Borst, Martin H. Zietse, Robert Danser, A. H. Jan Hoorn, Ewout J. |
author_facet | Bovée, Dominique M. Roksnoer, Lodi C. W. van Kooten, Cornelis Rotmans, Joris I. Vogt, Liffert de Borst, Martin H. Zietse, Robert Danser, A. H. Jan Hoorn, Ewout J. |
author_sort | Bovée, Dominique M. |
collection | PubMed |
description | BACKGROUND: Acidosis-induced kidney injury is mediated by the intrarenal renin-angiotensin system, for which urinary renin is a potential marker. Therefore, we hypothesized that sodium bicarbonate supplementation reduces urinary renin excretion in patients with chronic kidney disease (CKD) and metabolic acidosis. METHODS: Patients with CKD stage G4 and plasma bicarbonate 15–24 mmol/l were randomized to receive sodium bicarbonate (3 × 1000 mg/day, ~ 0.5 mEq/kg), sodium chloride (2 × 1,00 mg/day), or no treatment for 4 weeks (n = 15/arm). The effects on urinary renin excretion (primary outcome), other plasma and urine parameters of the renin-angiotensin system, endothelin-1, and proteinuria were analyzed. RESULTS: Forty-five patients were included (62 ± 15 years, eGFR 21 ± 5 ml/min/1.73m(2), plasma bicarbonate 21.7 ± 3.3 mmol/l). Sodium bicarbonate supplementation increased plasma bicarbonate (20.8 to 23.8 mmol/l) and reduced urinary ammonium excretion (15 to 8 mmol/day, both P < 0.05). Furthermore, a trend towards lower plasma aldosterone (291 to 204 ng/L, P = 0.07) and potassium (5.1 to 4.8 mmol/l, P = 0.06) was observed in patients receiving sodium bicarbonate. Sodium bicarbonate did not significantly change the urinary excretion of renin, angiotensinogen, aldosterone, endothelin-1, albumin, or α1-microglobulin. Sodium chloride supplementation reduced plasma renin (166 to 122 ng/L), and increased the urinary excretions of angiotensinogen, albumin, and α1-microglobulin (all P < 0.05). CONCLUSIONS: Despite correction of acidosis and reduction in urinary ammonium excretion, sodium bicarbonate supplementation did not improve urinary markers of the renin-angiotensin system, endothelin-1, or proteinuria. Possible explanations include bicarbonate dose, short treatment time, or the inability of urinary renin to reflect intrarenal renin-angiotensin system activity. GRAPHIC ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-8494695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-84946952021-10-19 Effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial Bovée, Dominique M. Roksnoer, Lodi C. W. van Kooten, Cornelis Rotmans, Joris I. Vogt, Liffert de Borst, Martin H. Zietse, Robert Danser, A. H. Jan Hoorn, Ewout J. J Nephrol Original Article BACKGROUND: Acidosis-induced kidney injury is mediated by the intrarenal renin-angiotensin system, for which urinary renin is a potential marker. Therefore, we hypothesized that sodium bicarbonate supplementation reduces urinary renin excretion in patients with chronic kidney disease (CKD) and metabolic acidosis. METHODS: Patients with CKD stage G4 and plasma bicarbonate 15–24 mmol/l were randomized to receive sodium bicarbonate (3 × 1000 mg/day, ~ 0.5 mEq/kg), sodium chloride (2 × 1,00 mg/day), or no treatment for 4 weeks (n = 15/arm). The effects on urinary renin excretion (primary outcome), other plasma and urine parameters of the renin-angiotensin system, endothelin-1, and proteinuria were analyzed. RESULTS: Forty-five patients were included (62 ± 15 years, eGFR 21 ± 5 ml/min/1.73m(2), plasma bicarbonate 21.7 ± 3.3 mmol/l). Sodium bicarbonate supplementation increased plasma bicarbonate (20.8 to 23.8 mmol/l) and reduced urinary ammonium excretion (15 to 8 mmol/day, both P < 0.05). Furthermore, a trend towards lower plasma aldosterone (291 to 204 ng/L, P = 0.07) and potassium (5.1 to 4.8 mmol/l, P = 0.06) was observed in patients receiving sodium bicarbonate. Sodium bicarbonate did not significantly change the urinary excretion of renin, angiotensinogen, aldosterone, endothelin-1, albumin, or α1-microglobulin. Sodium chloride supplementation reduced plasma renin (166 to 122 ng/L), and increased the urinary excretions of angiotensinogen, albumin, and α1-microglobulin (all P < 0.05). CONCLUSIONS: Despite correction of acidosis and reduction in urinary ammonium excretion, sodium bicarbonate supplementation did not improve urinary markers of the renin-angiotensin system, endothelin-1, or proteinuria. Possible explanations include bicarbonate dose, short treatment time, or the inability of urinary renin to reflect intrarenal renin-angiotensin system activity. GRAPHIC ABSTRACT: [Image: see text] Springer International Publishing 2020-12-31 2021 /pmc/articles/PMC8494695/ /pubmed/33382448 http://dx.doi.org/10.1007/s40620-020-00944-5 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Bovée, Dominique M. Roksnoer, Lodi C. W. van Kooten, Cornelis Rotmans, Joris I. Vogt, Liffert de Borst, Martin H. Zietse, Robert Danser, A. H. Jan Hoorn, Ewout J. Effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial |
title | Effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial |
title_full | Effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial |
title_fullStr | Effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial |
title_full_unstemmed | Effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial |
title_short | Effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial |
title_sort | effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494695/ https://www.ncbi.nlm.nih.gov/pubmed/33382448 http://dx.doi.org/10.1007/s40620-020-00944-5 |
work_keys_str_mv | AT boveedominiquem effectofsodiumbicarbonatesupplementationonthereninangiotensinsysteminpatientswithchronickidneydiseaseandacidosisarandomizedclinicaltrial AT roksnoerlodicw effectofsodiumbicarbonatesupplementationonthereninangiotensinsysteminpatientswithchronickidneydiseaseandacidosisarandomizedclinicaltrial AT vankootencornelis effectofsodiumbicarbonatesupplementationonthereninangiotensinsysteminpatientswithchronickidneydiseaseandacidosisarandomizedclinicaltrial AT rotmansjorisi effectofsodiumbicarbonatesupplementationonthereninangiotensinsysteminpatientswithchronickidneydiseaseandacidosisarandomizedclinicaltrial AT vogtliffert effectofsodiumbicarbonatesupplementationonthereninangiotensinsysteminpatientswithchronickidneydiseaseandacidosisarandomizedclinicaltrial AT deborstmartinh effectofsodiumbicarbonatesupplementationonthereninangiotensinsysteminpatientswithchronickidneydiseaseandacidosisarandomizedclinicaltrial AT zietserobert effectofsodiumbicarbonatesupplementationonthereninangiotensinsysteminpatientswithchronickidneydiseaseandacidosisarandomizedclinicaltrial AT danserahjan effectofsodiumbicarbonatesupplementationonthereninangiotensinsysteminpatientswithchronickidneydiseaseandacidosisarandomizedclinicaltrial AT hoornewoutj effectofsodiumbicarbonatesupplementationonthereninangiotensinsysteminpatientswithchronickidneydiseaseandacidosisarandomizedclinicaltrial |